Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways
被引:49
作者:
Choi, JA
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Choi, JA
Park, MT
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Park, MT
Kang, CM
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Kang, CM
Um, HD
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Um, HD
Bae, S
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Bae, S
Lee, KH
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Lee, KH
Kim, TH
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Kim, TH
Kim, JH
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Kim, JH
Cho, CK
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Cho, CK
Lee, YS
论文数: 0引用数: 0
h-index: 0
机构:Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Lee, YS
论文数: 引用数:
h-index:
机构:
Chung, HY
Lee, SJ
论文数: 0引用数: 0
h-index: 0
机构:
Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South KoreaKorea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
Lee, SJ
[1
]
机构:
[1] Korea Inst Radiol & Med Sci, Lab Radiat Effect, Seoul 139706, South Korea
[2] Korea Inst Radiol & Med Sci, Lab Expt Pathol, Seoul 139706, South Korea
[3] Korea Inst Radiol & Med Sci, Oncol Mol Lab, Seoul 139706, South Korea
[4] Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea
[5] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea
It has been well known that Ras signaling is involved in various cellular processes, including proliferation, differentiation, and apoptosis. However, distinct cellular functions of Ras isozymes are not fully understood. Here we show the opposing roles of Ha-Ras and Ki-Ras genes in the modulation of cell sensitivity to ionizing radiation. Overexpression of active isoform of Ha-Ras (12V-Ha-Ras) in Rat2 cells increases resistance to the ionizing radiation. Constitutive activation of phosphoinositide-3-kinase (PI3K) and Akt is detected specifically in 12V-Ha-Ras-overexpressing cells. The specific PI3K inhibitor LY294002 inhibits PI3K/Akt signaling and potentiates the radiation-induced apoptosis, suggesting that activation of the PI3K/47;Akt signaling pathway is involved in the increased radio-resistance in cells overexpressing 12V-Ha-Ras. Overexpression of activated Ki-Ras (12V-Ki-Ras), on the other hand, markedly increases radiation sensitivity. The p38 mitogen-activated protein kinase (MAPK) activity is selectively enhanced by ionizing radiation in cells overexpressing 12V-Ki-Ras. The specific p38 MAPK inhibitor, PD169316, or dominant-negative p38 MAPK decreases radiation-induced cell death. We further show that the mechanism that underlies potentiation of cell death in cells overexpressing 12V-Ki-Ras involves Bax translocation to the mitochondrial membrane. Elevated Bax translocation following ionizing irradiation in 12V-Ki-Ras-overexpressing cells is completely inhibited by PD169316 or dominant-negative p38 MAPK. In addition, introduction of cells with RacN17, a dominant-negative mutant of Rac, resulted in a marked inhibition of radiation-induced Bax translocation and apoptotic cell death as well as p38 MAPK activation. Taken together, these findings explain the opposite effects of Ha-Ras and Ki-Ras on modulation of radiosensitivity, and suggest that differential activation of PI3K/Akt and Rac/p38 MAPK signaling by Ha-Ras and Ki-Ras may account for the opposing response to the ionizing radiation. These data provide an explanation for the diverse biological functions of Ras isozymes, and partly accounts for the differential response of transformed cells to anticancer treatments.